Physician profile
Jennifer Hendricks
NPI 1386841716
$1,381.74
in general payments reported to CMS, 2019-2025
13 companies · $572 in 2025
The $572 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.84 · 2020: $42.66 · 2021: $41.90 · 2022: $41.95 · 2023: $303 · 2024: $355 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,229.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $529.34 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Abbvie INC. | $320.83 | 2021-2025 | |
| Novo Nordisk INC | $112.52 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $79.75 | 2022-2024 | Mounjaro |
| Exact Sciences Corporation | $65.76 | 2023-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $56.76 | 2023 | |
| Glaxosmithkline, LLC. | $53.09 | 2023-2024 | Trelegy Ellipta, Arexvy |
| Gilead Sciences, INC. | $48.39 | 2025 | |
| Sanofi Pasteur INC. | $30.69 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.06 | 2025 | Xifaxan |
| Tactile Systems Technology INC | $20.11 | 2025 | Flexitouch Plus, Nimbl |
| Biogen, INC. | $19.67 | 2025 | Zurzuvae |
| Pfizer INC. | $15.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.